Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B

Annette Von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W.G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe

Research output: Contribution to journal › Article

Original languageEnglish (US)
Pages (from-to)3241-3247
Number of pages7
JournalBlood Advances
Volume3
Issue number21
DOIs
StatePublished - Nov 12 2019

Fingerprint

Hemophilia B

ASJC Scopus subject areas

  • Hematology

Cite this

Drygalski, A. V., Giermasz, A., Castaman, G., Key, N. S., Lattimore, S., Leebeek, F. W. G., ... Pipe, S. W. (2019). Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B. Blood Advances, 3(21), 3241-3247. https://doi.org/10.1182/bloodadvances.2019000811

Etranacogene dezaparvovec (AMT-061 phase 2b) : Normal/near normal FIX activity and bleed cessation in hemophilia B. / Drygalski, Annette Von; Giermasz, Adam; Castaman, Giancarlo; Key, Nigel S.; Lattimore, Susan; Leebeek, Frank W.G.; Miesbach, Wolfgang; Recht, Michael; Long, Alison; Gut, Robert; Sawyer, Eileen K.; Pipe, Steven W.

In: Blood Advances, Vol. 3, No. 21, 12.11.2019, p. 3241-3247.

Research output: Contribution to journal › Article

Drygalski, AV, Giermasz, A, Castaman, G, Key, NS, Lattimore, S, Leebeek, FWG, Miesbach, W, Recht, M, Long, A, Gut, R, Sawyer, EK & Pipe, SW 2019, 'Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B', Blood Advances, vol. 3, no. 21, pp. 3241-3247. https://doi.org/10.1182/bloodadvances.2019000811
Drygalski AV, Giermasz A, Castaman G, Key NS, Lattimore S, Leebeek FWG et al. Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B. Blood Advances. 2019 Nov 12;3(21):3241-3247. https://doi.org/10.1182/bloodadvances.2019000811
Drygalski, Annette Von ; Giermasz, Adam ; Castaman, Giancarlo ; Key, Nigel S. ; Lattimore, Susan ; Leebeek, Frank W.G. ; Miesbach, Wolfgang ; Recht, Michael ; Long, Alison ; Gut, Robert ; Sawyer, Eileen K. ; Pipe, Steven W. / Etranacogene dezaparvovec (AMT-061 phase 2b) : Normal/near normal FIX activity and bleed cessation in hemophilia B. In: Blood Advances. 2019 ; Vol. 3, No. 21. pp. 3241-3247.
@article{4eb75a183c154a2db4ea0c49e39464ed,
title = "Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B",
author = "Drygalski, {Annette Von} and Adam Giermasz and Giancarlo Castaman and Key, {Nigel S.} and Susan Lattimore and Leebeek, {Frank W.G.} and Wolfgang Miesbach and Michael Recht and Alison Long and Robert Gut and Sawyer, {Eileen K.} and Pipe, {Steven W.}",
year = "2019",
month = "11",
day = "12",
doi = "10.1182/bloodadvances.2019000811",
language = "English (US)",
volume = "3",
pages = "3241--3247",
journal = "Blood advances",
issn = "2473-9529",
publisher = "American Society of Hematology",
number = "21",

}

TY - JOUR

T1 - Etranacogene dezaparvovec (AMT-061 phase 2b)

T2 - Normal/near normal FIX activity and bleed cessation in hemophilia B

AU - Drygalski, Annette Von

AU - Giermasz, Adam

AU - Castaman, Giancarlo

AU - Key, Nigel S.

AU - Lattimore, Susan

AU - Leebeek, Frank W.G.

AU - Miesbach, Wolfgang

AU - Recht, Michael

AU - Long, Alison

AU - Gut, Robert

AU - Sawyer, Eileen K.

AU - Pipe, Steven W.

PY - 2019/11/12

Y1 - 2019/11/12

UR - http://www.scopus.com/inward/record.url?scp=85074906798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074906798&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2019000811

DO - 10.1182/bloodadvances.2019000811

M3 - Article

C2 - 31698454

AN - SCOPUS:85074906798

VL - 3

SP - 3241

EP - 3247

JO - Blood advances

JF - Blood advances

SN - 2473-9529

IS - 21

ER -

Access to Document